Mereo BioPharma Group plc (MAH0) — Financial Flexibility Index
Mereo BioPharma Group plc (MAH0) has a Financial Flexibility Index of -1.54x as of December 2025. Free cash flow of €-7.68 Million (operating CF €-7.68 Million minus capex €0.00) represents -2% of total liabilities (€5.00 Million). Check MAH0 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mereo BioPharma Group plc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Mereo BioPharma Group plc across 10 annual periods. See MAH0 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Mereo BioPharma Group plc (2016–2025)
Year-by-year free cash flow to debt coverage for Mereo BioPharma Group plc. For the full company profile including market capitalisation, see Mereo BioPharma Group plc (MAH0) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.13x | €-30.65 Million | €-30.97 Million | €5.00 Million | ▼ -194.1% |
| 2024 | -2.08x | €-32.13 Million | €-32.83 Million | €15.42 Million | ▼ -60.6% |
| 2023 | -1.30x | €-20.71 Million | €-21.13 Million | €15.96 Million | ▲ +12.4% |
| 2022 | -1.48x | €-38.81 Million | €-38.82 Million | €26.21 Million | ▼ -1109.2% |
| 2021 | -0.12x | €-4.70 Million | €-5.24 Million | €38.41 Million | ▲ +66.3% |
| 2020 | -0.36x | €-28.32 Million | €-28.34 Million | €77.92 Million | ▲ +63.4% |
| 2019 | -0.99x | €-45.91 Million | €-45.93 Million | €46.19 Million | ▼ -48.4% |
| 2018 | -0.67x | €-23.11 Million | €-23.14 Million | €34.51 Million | ▲ +29.5% |
| 2017 | -0.95x | €-32.13 Million | €-32.15 Million | €33.85 Million | ▲ +76.0% |
| 2016 | -3.95x | €-29.66 Million | €-29.66 Million | €7.51 Million | — |